{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:25:32Z","timestamp":1792178732383,"version":"4.4.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymgmr.2026.101343","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:45:29Z","timestamp":1785447929000},"page":"101343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Plasma KL-6 reflects pulmonary severity and longitudinal response to enzyme replacement therapy in acid sphingomyelinase deficiency type B"],"prefix":"10.1016","volume":"48","author":[{"given":"Karla","family":"Cifuentes-Uribe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Guffon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Bouli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9gol\u00e8ne","family":"Turquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Acquaviva-Bourdain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline","family":"Froissart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Pettazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2026.101343_bb0005","series-title":"GeneReviews\u00ae [Internet], University of Washington, Seattle, WA, 1993\u20132023, updated April 27","article-title":"Acid sphingomyelinase deficiency","author":"Wasserstein","year":"2023"},{"key":"10.1016\/j.ymgmr.2026.101343_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/biom14020211","article-title":"The genetic basis, lung involvement, and therapeutic options in Niemann-pick disease: a comprehensive review","volume":"14","author":"Tirelli","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymgmr.2026.101343_bb0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13023-023-02686-6","article-title":"Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann-pick disease types A, B and A\/B)","volume":"18","author":"Geberhiwot","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13023-017-0572-x","article-title":"Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)","volume":"12","author":"McGovern","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13023-024-03174-1","article-title":"A retrospective study of morbidity and mortality of chronic acid sphingomyelinase deficiency in Germany","volume":"19","author":"Mengel","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ymgme.2018.11.014","article-title":"Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD)","volume":"126","author":"Wasserstein","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0035","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gim.2013.4","article-title":"Morbidity and mortality in type B Niemann-pick disease","volume":"15","author":"McGovern","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1186\/s12890-025-04023-y","article-title":"Clinical utility of lung diffusing capacity for carbon monoxide (DLco) in children: a retrospective single-center study","volume":"25","author":"Micic","year":"2025","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0045","article-title":"Plasma Lyso-sphingomyelin levels are positively associated with clinical severity in acid sphingomyelinase deficiency","volume":"28","author":"Breilyn","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109081","article-title":"Acid sphingomyelinase deficiency: laboratory diagnosis, genetic and epidemiologic aspects of a 50-year French cohort","volume":"145","author":"Froissart","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0055","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.gim.2022.03.021","article-title":"A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: one-year results","volume":"24","author":"Wasserstein","year":"2022","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0060","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/jcm12031173","article-title":"Serum KL-6 as a biomarker of progression at any time in fibrotic interstitial lung disease","volume":"12","author":"Jehn","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.resinv.2012.02.001","article-title":"Utility of KL-6\/MUC1 in the clinical management of interstitial lung diseases","volume":"50","author":"Ishikawa","year":"2012","journal-title":"Respir. Investig."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0070","first-page":"653","article-title":"Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia","volume":"44","author":"Kobayashi","year":"1996","journal-title":"Rinsho Byori"},{"key":"10.1016\/j.ymgmr.2026.101343_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181700","article-title":"LC-MS\/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: a novel tool for the screening of sphingolipidoses and Niemann-pick type C disease","volume":"12","author":"Pettazzoni","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2026.101343_bb0080","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1165\/rcmb.2020-0229OC","article-title":"Altered macrophage function associated with crystalline lung inflammation in acid sphingomyelinase deficiency","volume":"64","author":"Poczobutt","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0085","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1053\/rmed.2000.0942","article-title":"Pulmonary involvement in Niemann-pick disease: case report and literature review","volume":"94","author":"Minai","year":"2000","journal-title":"Respir. Med."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0090","article-title":"The impact of sphingomyelin on the pathophysiology and treatment response to olipudase alfa in acid sphingomyelinase deficiency","volume":"2","author":"Kumar","year":"2024","journal-title":"Genet. Med. Open"},{"key":"10.1016\/j.ymgmr.2026.101343_bb0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.virol.2021.11.006","article-title":"Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: a systematic review and meta-analyses","volume":"566","author":"Naderi","year":"2022","journal-title":"Virology"},{"key":"10.1016\/j.ymgmr.2026.101343_bb0100","article-title":"Prognostic value of serum Krebs von den Lungen-6 (KL-6) levels in COVID-19 pneumonia","volume":"84","author":"Letellier","year":"2023","journal-title":"Respir. Med. Res."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12216772","article-title":"Serum KL-6 as a candidate predictor of outcome in patients with SARS-CoV-2 pneumonia","volume":"12","author":"Kattner","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymgmr.2026.101343_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70039","article-title":"Exploring exhaled breath analysis in adults with chronic visceral acid sphingomyelinase deficiency to identify potential biomarkers of pulmonary involvement","volume":"48","author":"Eskes","year":"2025","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:49:13Z","timestamp":1789199353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426926000558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"alternative-id":["S2214426926000558"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101343","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma KL-6 reflects pulmonary severity and longitudinal response to enzyme replacement therapy in acid sphingomyelinase deficiency type B","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101343"}}